Ken MacLeod
Direktor/Vorstandsmitglied bei SEQUANA MEDICAL N.V.
Profil
Ken MacLeod is currently a Director at JenaValve Technology, Inc., a Director at Oxular Ltd., and a Non-Executive Director at Sequana Medical NV.
He has formerly held positions as a Director at On-X Life Technologies, Inc., Pharming Group NV, and Cryogenics, Inc. Dr. MacLeod received an undergraduate degree from The University of Manchester and a doctorate degree from The University of York.
Aktive Positionen von Ken MacLeod
Unternehmen | Position | Beginn |
---|---|---|
SEQUANA MEDICAL N.V. | Direktor/Vorstandsmitglied | 01.06.2023 |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | 05.04.2023 |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ken MacLeod
Unternehmen | Position | Ende |
---|---|---|
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | - |
Cryogenics, Inc.
Cryogenics, Inc. Oilfield Services/EquipmentIndustrial Services Cryogenics, Inc. manufactures equipment for the petrochemical industry. | Direktor/Vorstandsmitglied | - |
PHARMING GROUP N.V. | Direktor/Vorstandsmitglied | - |
Ausbildung von Ken MacLeod
The University of Manchester | Undergraduate Degree |
The University of York | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PHARMING GROUP N.V. | Health Technology |
SEQUANA MEDICAL N.V. | Health Technology |
Private Unternehmen | 4 |
---|---|
On-X Life Technologies, Inc.
On-X Life Technologies, Inc. Medical SpecialtiesHealth Technology On-X Life Technologies, Inc. develops, manufactures, and markets heart valve replacements. The firm offers prosthetic heart valves, pyrolytic carbon coating, and technical services in carbon based technology including medical design and product development. The company was founded by Jack C. Bokros in April 1994 and is headquartered in Austin, TX. | Health Technology |
Cryogenics, Inc.
Cryogenics, Inc. Oilfield Services/EquipmentIndustrial Services Cryogenics, Inc. manufactures equipment for the petrochemical industry. | Industrial Services |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Oxular Ltd.
Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Health Technology |